US gives conditional nod to Zoetis' bird flu vaccine for poultry
The U.S. Department of Agriculture has granted Zoetis conditional approval for its bird flu vaccine for poultry. This conditional license is intended for emergencies and is valid for a limited time. The approval comes as bird flu has infected nearly 70 people in the U.S., resulting in one death, primarily among farm workers. Zoetis specializes in animal healthcare, including vaccines and medicines, and received the license based on a reasonable expectation of efficacy.
Feb 14 (Reuters) - The U.S. Department of Agriculture gave Zoetis (ZTS.N) conditional approval to use its bird flu vaccine in poultry, the animal healthcare company said on Friday.
A conditional approval, called as a conditional license, is used for emergencies, limited market availability, or other special circumstance and is issued for a finite period of time.
Bird flu has infected nearly 70 people in the United States, with one death, since last April. Most of those infections have been among farm workers exposed to infected poultry or cows.
Zoetis, which deals with vaccines, medicines as well as diagnostic solutions for animals, said the conditional license was granted based on reasonable expectation of efficacy.
